Holmes-Hampton, Gregory P.
Kumar, Vidya P.
Biswas, Shukla
Stone, Sasha
Sharma, Neel K.
Legesse, Betre
Vercellino, Justin
Guha, Chandan
Eichenbaum, Gary
Ghosh, Sanchita P.
Article History
Received: 5 May 2023
Accepted: 10 September 2023
First Online: 14 September 2023
Competing interests
: The following authors VPK, SB, NKS, SS, BL, GHH, and SPG declare no conflict of interest. JV and CG are employee of Albert Einstein College of Medicine and declare no conflict of interest. GE, an employee of Johnson & Johnson and its subsidiary Janssen Pharmaceuticals working on the development of JNJ‑26366821 and stand to benefit financially from the successful development of the compound.